Particularly in ccRCC, HIF-1α appears to function as a tumor suppressor, and its expression is often silenced, whereas HIF-2α acts as a driver of ccRCC progression9,13,14. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.